India

What if ‘Herd Immunity’ Is Closer Than Scientists Thought?

Aug
18

To achieve so-called herd immunity — the point at which the virus can no longer spread widely because there are not enough vulnerable humans — scientists have suggested that perhaps 70 percent of a given population must be immune, through vaccination or because they survived the infection.

Now some researchers are wrestling with a hopeful possibility. In interviews with The New York Times, more than a dozen scientists said that the threshold is likely to be much lower: just 50 percent, perhaps even less. If that’s true, then it may be possible to turn back the coronavirus more quickly than once thought.

The new estimates result from complicated statistical modeling of the pandemic, and the models have all taken divergent approaches, yielding inconsistent estimates. It is not certain that any community in the world has enough residents now immune to the virus to resist a second wave.

Problem, Solution, SitRep, or ?: 
Posted By mike kraft read more

UPDATE Tracking the spread of the novel coronavirus --Reuters

Aug
16

At least 766,383 people globally have died from COVID-19 and 21,577,190 have been infected by the novel coronavirus that causes it, following an outbreak that started in Wuhan, China, in early December. The World Health Organization referred to it as a pandemic on March 11, 2020.

Problem, Solution, SitRep, or ?: 
Posted By mike kraft read more

Asia Today: Restrictions in S. Korea, India cases hit 2.5M

Aug
15

SEOUL, South Korea (AP) — South Korea on Saturday announced stronger social distancing restrictions for its greater capital area where a surge in COVID-19 cases has threatened to erase the hard-won gains against the virus.

Problem, Solution, SitRep, or ?: 
Posted By mike kraft read more

Clinical Trials of Coronavirus Drugs Are Taking Longer Than Expected

Aug
14

 

As the coronavirus pandemic continues to wreak havoc in the United States and treatments are needed more than ever, clinical trials for some of the most promising experimental drugs are taking longer than expected.

Researchers at a dozen clinical trial sites said that testing delays, staffing shortages, space constraints and reluctant patients were complicating their efforts to test monoclonal antibodies, man-made drugs that mimic the molecular soldiers made by the human immune system.

Problem, Solution, SitRep, or ?: 
Posted By mike kraft read more

Pages

Subscribe to India
howdy folks

User login

What is the weather on the sun

Language

English Arabic Danish Dutch Filipino Finnish French German Greek Haitian Creole Hebrew Hindi Indonesian Irish Italian Japanese Korean Persian Portuguese Russian Spanish Swedish Thai Turkish Ukrainian Vietnamese

Anonymous's groups in this site

User is not a member of any group.

Your groups across all your sites

User is not a member of any group.

Who's online

There are currently 0 users online.

Facebook  Twitter  RSS